News

Postmenopausal women with higher levels of body fat have a significantly increased risk of developing breast cancer even if they have a normal body mass index (BMI), according to a new study.

Reflecting a national movement, Weill Cornell Medicine puts increased focus on student and physician wellness.

A study of the dual pathways that process the essential vitamin folate by Weill Cornell Medicine investigators unexpectedly revealed a new way the cancer drug methotrexate works and may suggest strategies to boost its cancer-killing effects.

Awards, honors, prizes and achievements for the month of November.

Dr. Said Ibrahim has been appointed the inaugural senior associate dean for diversity and inclusion at Weill Cornell Medicine.

Common drug treatments that lead to changes in gut fungi can persistently exacerbate allergic airway diseases such as asthma.

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. 

Measuring brain activity in response to hearing a brief narrative can identify patients with severe brain injury who have preserved high-level cognition despite showing limited or no consciousness at the bedside, according to a study by Weill Cornell Medicine researchers.

Scientists can now discover how the fine details of gene activity differ from one cell type to another in a tissue sample, thanks to a technique invented by Weill Cornell Medicine researchers.

Dr. Massimo Loda Appointed Chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and Pathologist-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center

Consuming a high-fat, high-sugar diet causes a harmful accumulation of fat in the liver that may not reverse even after switching to a healthier diet, according to a new study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Eight Weill Cornell Medicine faculty members have been selected for the fifth round of the Daedalus Fund for Innovation awards, a pioneering institutional program that helps advance promising applied and translational research projects and emerging technologies that have commercial potential.

Combining radiation with an immune system-boosting therapy called ipilimumab led to regression of metastatic tumors not targeted by the radiation in lung cancer patients, according to results of an early clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Gastroenterologist Dr. David Carr-Locke and colleagues describe a new bodily structure—and the media takes notice.

Hospitals that routinely perform a heart valve replacement procedure that requires open heart surgery are more likely to adopt a newer, less invasive technique, according to a new study.

In recognition of its outstanding commitment to diversity and inclusion, Weill Cornell Medicine has been awarded INSIGHT Into Diversity magazine’s 2018 Health Professions Higher Education Excellence in Diversity (HEED) Award.

Awards, honors, prizes and achievements for the month of October.

World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 for the sixth annual Appel Alzheimer’s Disease Research Institute Symposium, sponsored by the Appel Institute and its home department, the Feil Family Brain and Mind Research Institute. Every year, the symposium highlights the latest discoveries in the field, as researchers work their way toward a cure.

Weill Cornell Medicine investigators Dr. David Lyden and Dr. Ari Melnick have been awarded Outstanding Investigator Awards from the National Cancer Institute.

A dynamic culture of mentorship should be raised to the level of a major strategic priority at academic medical centers to maximize their success, according to new commentary by administrators from Weill Cornell Medicine and the Association of American Medical Colleges.